Karo Pharma AB (publ) agreed to acquire of Six brands of Teva for DKK 84 million on December 5, 2022. Decubal, Lactocare, Apobase, Flux, Dailycare and Fludent, which are primarily sold in the Nordics. The acquisition is expected to be final on 1 April, 2023.

The annual turnover for the acquired brands is DKK 330 million.